{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:11:33Z","timestamp":1790118693869,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Municipal Health Bureau","award":["NO.MS20016"],"award-info":[{"award-number":["NO.MS20016"]}]},{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project","award":["NO.TJYXZDXK-055B"],"award-info":[{"award-number":["NO.TJYXZDXK-055B"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04939-7","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T02:16:35Z","timestamp":1753409795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The value of CD47 and CAP1 levels in early diagnosis and MACE prediction for patients with non-ST-segment\u00a0elevation myocardial infarction"],"prefix":"10.1186","volume":"25","author":[{"given":"Mingyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuecheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"issue":"25","key":"4939_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: A compass for future health. J Am Coll Cardiol. 2022;80(25):2361\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"9524","key":"4939_CR2","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","volume":"367","author":"AD Lopez","year":"2006","unstructured":"Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747\u201357.","journal-title":"Lancet"},{"issue":"38","key":"4939_CR3","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, J\u00fcni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Rubini Gimenez M, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B, ESC Scientific Document Group. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720\u2013826.","journal-title":"Eur Heart J"},{"issue":"4","key":"4939_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0002-9149(02)02489-X","volume":"90","author":"PG Steg","year":"2002","unstructured":"Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, Sadiq I, Kasper R, Rushton-Mellor SK, Anderson FA. GRACE investigators. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the global registry of acute coronary events (GRACE). Am J Cardiol. 2002;90(4):358\u201363.","journal-title":"Am J Cardiol"},{"issue":"3","key":"4939_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S, ESC Scientific Document Group. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-Segment elevation of the European society of cardiology (ESC). Eur Heart J. 2016;37(3):267\u2013315.","journal-title":"Eur Heart J"},{"issue":"4","key":"4939_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/1076029613505763","volume":"21","author":"RC Oncel","year":"2015","unstructured":"Oncel RC, Ucar M, Karakas MS, Akdemir B, Yanikoglu A, Gulcan AR, Altekin RE, Demir I. Relation of neutrophil-to-lymphocyte ratio with GRACE risk score to in-hospital cardiac events in patients with ST-segment elevated myocardial infarction. Clin Appl Thromb Hemost. 2015;21(4):383\u20138.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"4939_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","volume":"124","author":"P Libby","year":"2019","unstructured":"Libby P, Pasterkamp G, Crea F, Jang IK. Reassessing the mechanisms of acute coronary syndromes. Circ Res. 2019;124(1):150\u201360.","journal-title":"Circ Res"},{"issue":"6","key":"4939_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrneph.2017.51","volume":"13","author":"GK Gistera, Hansson","year":"2017","unstructured":"Gistera, Hansson GK. The immunology of atherosclerosis[J]. Nat Rev Nephrol. 2017;13(6):368\u201380.","journal-title":"Nat Rev Nephrol"},{"issue":"7614","key":"4939_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature18935","volume":"536","author":"Y Kojima","year":"2016","unstructured":"Kojima Y, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, Direnzo D, Nanda V, Ye J, Connolly AJ, Schadt EE, Quertermous T, Betancur P, Maegdefessel L, Matic LP, Hedin U, Weissman IL, Leeper NJ. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536(7614):86\u201390.","journal-title":"Nature"},{"key":"4939_CR10","doi-asserted-by":"publisher","first-page":"484497","DOI":"10.1016\/j.cmet.2014.01.013","volume":"19","author":"S Lee","year":"2014","unstructured":"Lee S, Lee HC, Kwon YW, Lee SE, Cho Y, Kim J, Lee S, Kim JY, Lee J, Yang HM, Jung M, Nam I, Chung KY, Lazar J, M. A., and, Kim HS. Adenylyl cyclase associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes. Cell Metab. 2014;19:484497.","journal-title":"Cell Metab"},{"issue":"1122","key":"4939_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/postgradmedj-2019-136409","volume":"95","author":"Y Chen","year":"2019","unstructured":"Chen Y, Tao Y, Zhang L, Xu W, Zhou X. Diagnostic and prognostic value of biomarkers in acute myocardial infarction. Postgrad Med J. 2019;95(1122):210\u20136.","journal-title":"Postgrad Med J"},{"key":"4939_CR12","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1073\/pnas.1121623109","volume":"109","author":"SB Willingham","year":"2016","unstructured":"Willingham SB, et al. The CD47-signal regulatory protein alpha (SIRP\u03b1) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci USA. 2016;109:6662\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4939_CR13","doi-asserted-by":"publisher","first-page":"1348852","DOI":"10.3389\/fimmu.2024.1348852","volume":"15","author":"Y Xu","year":"2024","unstructured":"Xu Y, Jiang P, Xu Z, Ye H. Opportunities and challenges for anti-CD47 antibodies in hematological malignancies. Front Immunol. 2024;15:1348852.","journal-title":"Front Immunol"},{"key":"4939_CR14","doi-asserted-by":"crossref","unstructured":"Yu WB, Ye ZH, Chen X, et al. The development of small-mole-cule inhibitors targeting CD47 [J]. Volume S1359\u20136446. Drug Discov Today; 2020. pp. 30468\u20132. 20.","DOI":"10.1016\/j.drudis.2020.11.003"},{"issue":"1","key":"4939_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1134\/S0006297918010066","volume":"83","author":"GV Kakurina","year":"2018","unstructured":"Kakurina GV, Kolegova ES, Kondakova IV. Adenylyl Cyclase-Associated protein 1: structure, regulation, and participation in cellular processes. Biochem (Mosc). 2018;83(1):45\u201353.","journal-title":"Biochem (Mosc)"},{"issue":"15","key":"4939_CR16","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1093\/cvr\/cvab369","volume":"118","author":"B Singla","year":"2022","unstructured":"Singla B, Lin HP, Ahn W, Xu J, Ma Q, Sghayyer M, Dong K, Cherian-Shaw M, Zhou J, Huo Y, White J, Cs\u00e1nyi G. Loss of myeloid cell-specific SIRP\u03b1, but not CD47, attenuates inflammation and suppresses atherosclerosis. Cardiovasc Res. 2022;118(15):3097\u2013111.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"4939_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s44161-022-00023-x","volume":"1","author":"KU Jarr","year":"2022","unstructured":"Jarr KU, Ye J, Kojima Y, Ye Z, Gao H, Schmid S, Luo L, Baylis RA, Lotfi M, Lopez N, Eberhard AV, Smith BR, Weissman IL, Maegdefessel L, Leeper NJ. The pleiotropic benefits of Statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis. Nat Cardiovasc Res. 2022;1(3):253\u201362. https:\/\/doi.org\/10.1038\/s44161-022-00023-x. Epub 2022 Mar 7.","journal-title":"Nat Cardiovasc Res"},{"key":"4939_CR18","doi-asserted-by":"publisher","first-page":"14802","DOI":"10.1038\/ncomms14802","volume":"8","author":"PA Betancur","year":"2017","unstructured":"Betancur PA, Abraham BJ, Yiu YY, Willingham SB, Khameneh F, Zarnegar M, Kuo AH, McKenna K, Kojima Y, Leeper NJ, Ho P, Gip P, Swigut T, Sherwood RI, Clarke MF, Somlo G, Young RA, Weissman IL. A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer. Nat Commun. 2017;8:14802.","journal-title":"Nat Commun"},{"key":"4939_CR19","doi-asserted-by":"crossref","unstructured":"Liu J, Wang L, Zhao F, Tseng S, Narayanan C, Shura L, Willingham S, Howard M, Prohaska S, Volkmer J, Chao M, Weissman IL, Majeti R. Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential. PLoS One. 2015;10(9):e0137345. pcked=\"1\">","DOI":"10.1371\/journal.pone.0137345"},{"issue":"3","key":"4939_CR20","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.jtcvs.2014.11.002","volume":"149","author":"SD Fihn","year":"2015","unstructured":"Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, Fonarow GC, Lange RA, Levine GN, Maddox TM, Naidu SS, Ohman EM, Smith PK, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, American College of Cardiology\/Americal Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; Preventive ardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. Of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American college of cardiology\/american heart association task force on practice guidelines, and the American association for thoracic surgery, preventive cardiovascular nurses association, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Thorac Cardiovasc Surg. 2015;149(3):e5\u201323. 2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"4939_CR21","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1038\/s41598-019-46942-x","volume":"9","author":"D Engelbertsen","year":"2019","unstructured":"Engelbertsen D, Autio A, Verwilligen RAF, Depuydt MAC, Newton G, Rattik S, Levinsohn E, Saggu G, Jarolim P, Wang H, Velazquez F, Lichtman AH, Luscinskas FW. Increased lymphocyte activation and atherosclerosis in CD47-deficient mice. Sci Rep. 2019;9(1):10608.","journal-title":"Sci Rep"},{"issue":"2","key":"4939_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41565-019-0619-3","volume":"15","author":"AM Flores","year":"2020","unstructured":"Flores AM, Hosseini-Nassab N, Jarr KU, Ye J, Zhu X, Wirka R, Koh AL, Tsantilas P, Wang Y, Nanda V, Kojima Y, Zeng Y, Lotfi M, Sinclair R, Weissman IL, Ingelsson E, Smith BR, Leeper NJ. Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. Nat Nanotechnol. 2020;15(2):154\u201361.","journal-title":"Nat Nanotechnol"},{"issue":"12","key":"4939_CR23","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1161\/ATVBAHA.107.155390","volume":"27","author":"JS Isenberg","year":"2007","unstructured":"Isenberg JS, Hyodo F, Pappan LK, et al. Blocking thrombospondin-1 \/ CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia [J]. Arterioscler Thromb Vasc Biol. 2007;27(12):2582\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"4939_CR24","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1177\/0300060518799612","volume":"46","author":"J Zhang","year":"2018","unstructured":"Zhang J, Jin S, Guo X, et al. Targeting the CD47-SIRPalpha signaling axis: current studies on B-cell lymphoma immunotherapy[J]. J Int Med Res. 2018;46(11):4418\u201326.","journal-title":"J Int Med Res"},{"issue":"5","key":"4939_CR25","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1159\/000453170","volume":"40","author":"HB Wang","year":"2016","unstructured":"Wang HB, Yang J, Ding JW, Chen LH, Li S, Liu XW, Yang CJ, Fan ZX, Yang J. RNAi-Mediated Down-Regulation of CD47 protects against Ischemia\/Reperfusion-Induced myocardial damage via activation of eNOS in a rat model. Cell Physiol Biochem. 2016;40(5):1163\u201374.","journal-title":"Cell Physiol Biochem"},{"key":"4939_CR26","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1038\/s41388-021-01789-3","volume":"40","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Tang Q, Liu W, et al. Novel role of CAP1 in regulation RNA polymerase II-mediated transcription elongation depends on its actin-depolymerization activity in nucleoplasm. Oncogene. 2021;40:3492\u2013509.","journal-title":"Oncogene"},{"issue":"3","key":"4939_CR27","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.cmet.2014.01.013","volume":"19","author":"S Lee","year":"2014","unstructured":"Lee S, Lee HC, Kwon YW, Lee SE, Cho Y, Kim J, Lee S, Kim JY, Lee J, Yang HM, Mook-Jung I, Nam KY, Chung J, Lazar MA, Kim HS. Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes. Cell Metab. 2014;19(3):484\u201397.","journal-title":"Cell Metab"},{"issue":"2","key":"4939_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/eurheartj\/ehz566","volume":"41","author":"HD Jang","year":"2020","unstructured":"Jang HD, Lee SE, Yang J, Lee HC, Shin D, Lee H, Lee J, Jin S, Kim S, Lee SJ, You J, Park HW, Nam KY, Lee SH, Park SW, Kim JS, Kim SY, Kwon YW, Kwak SH, Yang HM, Kim HS. Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin\/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin\/kexin type-9. Eur Heart J. 2020;41(2):239\u201352.","journal-title":"Eur Heart J"},{"key":"4939_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000503416","volume":"10","author":"J Munjas","year":"2020","unstructured":"Munjas J, Sopic M, Bogavac-Stanojevic N, et al. Serum resistin, adenylate cyclase-associated protein 1 gene expression, and carotid intima-media thickness in patients with end-stage renal disease and healthy controls. Cardiorenal Med. 2020;10:51\u201360.","journal-title":"Cardiorenal Med"},{"key":"4939_CR30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/eci.12787","volume":"47","author":"J Munjas","year":"2017","unstructured":"Munjas J, Sopic M, Spasojevic-Kalimanovska V, et al. Association of adenylate cyclase-associated protein 1 with coronary artery disease. Eur J Clin Invest. 2017;47:659\u201366.","journal-title":"Eur J Clin Invest"},{"issue":"39","key":"4939_CR31","doi-asserted-by":"publisher","first-page":"e34700","DOI":"10.1097\/MD.0000000000034700","volume":"102","author":"D Jin","year":"2023","unstructured":"Jin D, Li X, Cong H, You B, Ma Y, Hu Y, Zhang J. Role of serum CAP1 protein in the diagnosis of patients with first-time acute myocardial infarction. Med (Baltim). 2023;102(39):e34700.","journal-title":"Med (Baltim)"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04939-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T22:43:54Z","timestamp":1757285034000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04939-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4939"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04939-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"3 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work has been carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association.Informed consent was obtained from all subjects, and approval was granted by the Ethics Committee of Tianjin Chest Hospital(Ethics Approval:2024YS-013-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"541"}}